Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NVNO - enVVeno Medical Corp

IEX Last Trade
3.01
-0.020   -0.664%

Share volume: 3,790
Last Updated: Fri 27 Dec 2024 04:30:27 PM CET
Surgical and Medical Instrument Manufacturing : -0.37%

PREVIOUS CLOSE
CHG
CHG%
$3.03
-0.02
-0.66%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-3.09%
1 Month
-12.15%
3 Months
-37.33%
6 Months
-45.24%
1 Year
-43.26%
2 Year
-38.02%
Key data
Stock price
$3.01
P/E Ratio 
0.00
DAY RANGE
$2.95 - $3.10
EPS 
$0.00
52 WEEK RANGE
$2.64 - $6.97
52 WEEK CHANGE
-$46.69
MARKET CAP 
70.116 M
YIELD 
N/A
SHARES OUTSTANDING 
13.330 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/24/2024
BETA 
0.76
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$246,558
AVERAGE 30 VOLUME 
$159,619
Company detail
CEO: Robert A. Berman
Region: US
Website: envveno.com
Employees: 30
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

enVVeno Medical Corporation focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the. treatment of severe deep venous chronic venous insufficiency.

Recent news